The TECNIS PureSee IOL addresses both cataract-related vision loss and presbyopia, which affects near vision as eyes age.

Johnson & Johnson (NYSE:JNJ) received FDA approval for its TECNIS PureSee IOL, an extended depth of focus intraocular lens for cataract patients. The lens is described as the first of its kind in the ...

The Tecnis PureSee IOL is the first FDA-approved extended depth of focus IOL maintaining contrast sensitivity comparable to ...

Johnson & Johnson (JNJ) announced on Thursday that the U.S. Food and Drug Administration (FDA) approved its Tecnis PureSee intraocular lens (IOL), giving eye surgeons a new lens option for use in ...

Johnson & Johnson (NYSE: JNJ) announced that it received FDA approval for its Tecnis PureSee intraocular lens (IOL) for cataract surgery.

To investigate the causal relationship between acute postoperative endophthalmitis (POE) after cataract surgery and the biomaterial properties of the intraocular lens (IOLs) implanted. This ...

HHS’ Office of the Inspector General issued a favorable result regarding a proposal to offer discounts to certain ASCs in intraocular lenses and supplies in cataract surgery, law firm Epstein Becker ...

BVI launched an intraocular lens in the U.S. market for patients in need of cataract surgery. BVI launched the IPure, which it’s marketing as the first and only preloaded aspheric monofocal ...

American Hospital Supply Corp., a unit of Baxter Travenol Laboratories Inc., has received approval from the Food and Drug Administration to market two kinds of intraocular lenses that correct vision ...

Between 1998 and 2004 at one Swiss hospital, 133 eyes (78 patients) underwent placement of a V4 model implantable Collamer® lens (ICL; Staar Surgical, Monrovia, California), a phakic posterior chamber ...